Angel One has released its key business metrics for September 2025 and Q2 FY26. The client base reached 34.08 million, a 24% year-over-year increase. Average client funding book grew to ₹55.53 billion, up 35.8% year-over-year. Unique MF SIPs registered were 786,570 in September. Overall ADTO based on notional turnover was ₹48,183 billion, up 0.5% year-over-year.

Client Growth and Acquisition

Angel One’s client base expanded to 34.08 million in September 2025, reflecting a 1.5% month-over-month increase and a substantial 24% year-over-year growth. The company acquired 0.55 million new clients during the month.

Funding and Turnover Metrics

The average client funding book stood at ₹55.53 billion in September 2025, marking a 4.9% increase compared to the previous month and a 35.8% rise year-over-year. The number of orders processed reached 127.57 million. Unique MF SIPs registered were 786,570 in September.

Average Daily Turnover (ADTO)

Overall Average Daily Turnover (ADTO), based on notional turnover, reached ₹48,183 billion in September 2025, showing a 5.1% month-over-month increase. ADTO for Futures & Options (F&O) was ₹46,712 billion. Based on option premium turnover, overall ADTO was ₹1,594 billion, and F&O ADTO was ₹123 billion.

Market Share

Angel One’s retail turnover market share, based on option premium turnover, was 20.6% for overall equity and 21.8% for F&O. The cash turnover market share stood at 19.0%, while the commodity turnover market share was 64.3%.

Q2 FY26 Performance

For Q2 FY26, the client base averaged 34.08 million. The average client funding book was ₹53.05 billion. The total number of orders for the quarter was 360.43 million, with an average daily order count of 5.63 million. Overall ADTO based on notional turnover for Q2 FY26 reached ₹45,087 billion, and overall ADTO based on option premium turnover reached ₹1,381 billion.

Source: BSE

Kalyan Jewellers announced a consolidated revenue growth of approximately 30% for Q2 FY2026, compared to the same period last year. India operations grew by around 31%, driven by strong wedding demand and the festive season. International operations saw a 17% increase. The company launched 15 Kalyan showrooms in India and 2 internationally during the quarter.

Strong Revenue Performance

Kalyan Jewellers reported a consolidated revenue growth of approximately 30% for the quarter ended September 30, 2025 (Q2 FY2026), compared to the corresponding period in the previous financial year.

India Operations Growth

The company’s India operations witnessed revenue growth of approximately 31% during Q2 FY2026, driven by robust wedding demand and a strong start to the festive season. The quarter recorded healthy same-store-sales-growth of approximately 16%.

International Performance

International operations recorded revenue growth of approximately 17% for the recently concluded quarter. Specifically, the Middle East saw revenue growth of approximately 10% for Q2 FY2026. International markets contributed approximately 12% to the consolidated revenue for the quarter.

Candere Performance

The digital-first jewellery platform, Candere, recorded a revenue growth of approximately 127% during the recently concluded quarter.

Showroom Expansion

During Q2 FY2026, the company launched 15 Kalyan showrooms in India and 2 showrooms in the Middle East. It also launched 15 Candere showrooms in India.

Debt Reduction Update

Kalyan Jewellers has secured approval from the lead bank for the release of real estate collateral pertaining to debt repaid and has resumed the next round of debt reduction.

Current Showroom Count

As of September 30, 2025, the total number of showrooms across India and the Middle East stood at 436 (Kalyan India – 300, Kalyan Middle East – 38, Kalyan USA – 2, Candere – 96).

Outlook

The ongoing quarter has started off well, and the company is encouraged by robust footfalls across all its major markets. They are upbeat about the ongoing season and are fully prepared with fresh collections, campaigns and launch of 15 more Kalyan showrooms before Diwali.

Source: BSE

The Indian Energy Exchange (IEX) reported a 16.1% year-on-year increase in electricity traded volume for Q2FY26, reaching 35,217 MU. Real-Time Market (RTM) achieved growth of 39.1% YoY. September 2025 saw a 7.1% YoY increase with a volume of 11,065 MU. Renewable Energy Certificates traded in Q2FY26 stood at 44.22 lakh. Average Day-Ahead Market (DAM) price in Q2FY26 was Rs 3.93/unit.

Electricity Trading Volume Growth

IEX achieved electricity traded volume of 35,217 MU in Q2FY26, representing a 16.1% year-on-year growth. The Real-Time Market (RTM) segment experienced significant expansion, achieving a 39.1% YoY increase. The Green Market also demonstrated strong performance with a 17.7% YoY growth.

Key Market Segment Performance

The Real-Time Electricity Market (RTM) registered volumes of 14,925 MU during Q2 FY’26, reflecting a significant increase of 39.1% compared to Q2 FY’25. This segment accounted for 37.1% of the total traded volumes. In September ’25, RTM volume increased to 4,786 MU, up from 3,913 MU the previous year, marking a 22.3% YoY rise.

September 2025 Highlights

In September 2025, IEX achieved a monthly electricity traded volume of 11,065 MU, marking a 7.1% increase year-on-year. The RTM segment continued its growth trajectory, achieving a 22.3% YoY increase. The Green Market also showed substantial growth, with a 50% YoY increase.

Renewable Energy Certificate (REC) Market

During Q2 FY’26, a total of 44.22 lakh RECs were traded. Trading sessions held in September 2025 saw clearing prices of Rs.365/REC and Rs. 370/REC. REC traded volume in September’25 decreased by 39.2% on YoY basis.

Pricing Trends

The average DAM price in Q2FY26 stood at Rs 3.93/unit, lower by 12.5% YoY. The average RTM price was Rs 3.51/unit, lower by 16.1% YoY. In September 2025, the average DAM price was Rs 3.58/unit, lower by 14.5% YoY, and the average RTM price was Rs 3.31/unit, lower by 16.8% YoY.

Source: BSE

Nykaa anticipates accelerated growth in Q2 FY2026, with consolidated GMV growth close to thirties. This is compared to the mid-twenties in previous quarters, driven by fashion vertical growth and sustained healthy performance in the beauty segment. Nykaa’s Beauty vertical is expected to deliver NSV and Net Revenue growth of mid-twenties, marking more than ten consecutive quarters of sustained growth. Consolidated Net Revenue growth is projected to be mid-twenties in Q2 FY2026.

Overall Performance

Nykaa (FSN E-Commerce Ventures Limited), along with its subsidiaries, has demonstrated an accelerated growth momentum in Q2 FY2026. The company expects its Consolidated GMV growth to be close to thirties, a significant increase compared to the mid-twenties observed in the preceding quarters. This strong performance is primarily attributed to the renewed growth in the Fashion vertical, combined with the steady performance of the Beauty vertical.

Beauty Vertical

The Beauty vertical is expected to achieve NSV and Net Revenue growth in the mid-twenties. This milestone marks over ten consecutive quarters of sustained growth momentum. The growth is further fueled by House of Nykaa brands, which continue to experience rapid expansion, including acquired brands like Dot & Key, and homegrown brands such as Kay Beauty and Nykaa Cosmetics.

Fashion Vertical

Nykaa’s Fashion vertical is expected to deliver NSV growth of higher mid twenties, driven by strong traction in the core platform business. This growth is supported by expanding brand assortment and robust customer acquisition. The vertical’s Net Revenue growth is expected to improve to low twenties. The Net Revenue growth for the fashion vertical lags the NSV growth due to differences in the recognition of advertising and marketing income.

Consolidated Net Revenue

As a result of these performances, Nykaa anticipates another quarter of healthy performance. Consolidated Net Revenue growth is expected to be in the mid-twenties in Q2 FY2026, with an early start to the festive season as an additional factor. The recent GST reforms announced by the Government are expected to increase disposable income and drive long-term growth across several consumer and discretionary categories.

Source: BSE

Hindustan Zinc Limited has received an order from the Office of the Commissioner, Central Goods & Service Tax – Udaipur, confirming a penalty of ₹73,46,112. This is related to the reversal of CENVAT credit availed on cement used as input in mines between July 2016 and June 2017. The company intends to appeal the order and does not anticipate any material financial impact.

CENVAT Credit Penalty

Hindustan Zinc Limited has received an order regarding CENVAT credit. The penalty, issued by the Office of the Commissioner, Central Goods & Service Tax in Udaipur, amounts to ₹73,46,112, along with the applicable tax demand and interest.

Details of the Issue

The issue pertains to the reversal of CENVAT credit previously availed on cement. This cement was used as input in mines during the period from July 2016 to June 2017.

Company’s Response

The company plans to file an appeal against this order before the Appellate Authority within the stipulated timeframe. Based on the merits of its case, Hindustan Zinc is hopeful of a favorable outcome. The company does not foresee this order having a significant material financial impact.

Source: BSE

Bank of Baroda announced a 10.47% year-over-year growth in its global business as of September 30, 2025, reaching ₹27.79 trillion. The bank’s global advances increased by 11.90% YoY to ₹12.79 trillion, while global deposits grew by 9.28% YoY to ₹15.00 trillion. The bank continues to show positive performance across key financial metrics.

Key Financial Performance Highlights

As of September 30, 2025, Bank of Baroda’s global business has demonstrated significant growth:

• Global business grew by 10.47% year-over-year, reaching ₹27.79 trillion.
• Global advances increased by 11.90% year-over-year, amounting to ₹12.79 trillion.
• Global deposits showed a 9.28% year-over-year increase, totaling ₹15.00 trillion.

Bank of Baroda Performance (₹ in crore)

*Subject to Audit / Review by Statutory Central Auditors of Bank.

Excluding pool purchase

Source: BSE

Force Motors has announced its sales data for September 2025, indicating growth across domestic and export categories. Total domestic sales of Small Commercial Vehicles (SCV), Light Commercial Vehicles (LCV), Utility Vehicles (UV), and Sports Utility Vehicles (SUV) increased by 1.51% compared to September 2024. Export sales saw a more significant increase of 7.83%. Combined domestic and export sales also reflected positive momentum with a 1.79% increase year-over-year.

September 2025 Sales Performance

Force Motors has released its sales figures for September 2025, showcasing the company’s performance in both domestic and international markets. The data provides insights into the sales of Small Commercial Vehicles (SCV), Light Commercial Vehicles (LCV), Utility Vehicles (UV), and Sports Utility Vehicles (SUV).

Domestic Sales Analysis

In the domestic market, Force Motors recorded total sales of 2,486 units in September 2025, compared to 2,449 units in September 2024. This translates to a 1.51% increase in sales volume year-over-year. This demonstrates a positive trend in demand for the company’s vehicles within India.

Export Sales Performance

The export segment exhibited stronger growth, with sales reaching 124 units in September 2025, up from 115 units in the same month last year. This represents a substantial 7.83% increase, indicating growing international demand for Force Motors’ product lineup.

Combined Domestic and Export Sales

Combining both domestic and export sales, Force Motors sold a total of 2,610 units in September 2025, compared to 2,564 units in September 2024. The overall sales growth stands at 1.79%. This includes deemed exports of 15 numbers.

Source: BSE

Jubilant Pharmova is notifying shareholders about the pending transfer of unclaimed equity shares to the Investor Education and Protection Fund (IEPF). This action affects shares for which dividends have remained unclaimed for seven consecutive years. Shareholders have until October 10, 2025, to claim their dividends and prevent the transfer. Unclaimed dividends will be transferred to IEPF on November 1, 2025.

Unclaimed Dividends and Share Transfer

Jubilant Pharmova is reminding shareholders about the transfer of equity shares related to unclaimed dividends to the Investor Education and Protection Fund (IEPF). This transfer is in accordance with regulations governing unclaimed dividends for seven consecutive years.

Key Dates and Actions

Shareholders who have not claimed their dividends for the financial year 2017-18 and subsequent years are urged to take immediate action. To prevent the transfer of shares to the IEPF, shareholders must claim their dividends by October 10, 2025. The actual transfer to the IEPF is scheduled for November 1, 2025.

How to Claim

To claim unclaimed dividends, shareholders should apply to Alankit Assignments Limited. Contact them at 205-208 Anarkali Complex, Jhandewalan Extension, New Delhi – 110055. It’s important to submit all necessary documents before the October 10, 2025 deadline.

Required Documents for Claim

• Request letter duly signed by the shareholder(s).
• Self-attested copy of PAN Card(s) of shareholder(s).
• Photocopy of blank cancelled cheque.
• Original Share Certificate.

If shares are transferred to IEPF, shareholders can still claim them later by applying to the IEPF Authority. If shareholders still have old share certificates, they should surrender them to claim new share certificates.

Source: BSE

Mankind Pharma has received a certificate regarding the Depositories and Participants Regulations for the quarter ended September 30, 2025. The certificate, received from KFin Technologies Limited, confirms compliance with regulatory requirements related to dematerialization and rematerialization of shares. This announcement indicates Mankind Pharma’s adherence to regulatory standards.

Regulatory Compliance Confirmation

Mankind Pharma has secured a certificate confirming adherence to the Depositories and Participants Regulations for Q2 2025. This certificate was issued by KFin Technologies Limited, the Registrar and Share Transfer Agent for Mankind Pharma.

Details of the Certificate

The certificate confirms that, for the period between July 01, 2025, and September 30, 2025, KFin Technologies Limited did not receive any requests for dematerialization or rematerialization of shares of Mankind Pharma Limited. This is in accordance with the specified regulations.

Source: BSE